Biotransformation and toxicity of halogenated benzenes. 1994

C den Besten, and A Brouwer, and I M Rietjens, and P J van Bladeren
Department of Toxicology, Solvay Duphar B.V., Weesp, The Netherlands.

1. Multiple potentially harmful metabolites can be distinguished in the metabolic activation of halogenated benzenes: epoxides, phenols, benzoquinones and benzoquinone-derived glutathione conjugates. 2. The role of these (re-) active metabolites in the toxic effects induced by halogenated benzenes such as hepatotoxicity, nephrotoxicity, porphyria and thyroid toxicity is discussed. 3. Evidence is presented suggesting that the formation of reactive benzoquinone metabolites rather than the traditional epoxides is linked to halogenated benzene-induced hepatotoxicity. 4. A crucial role for the benzoquinone-derived glutathione adducts in halogenated benzene-induced nephrotoxicity is clearly established. 5. Although metabolic activation appears to be involved in porphyria, the nature of the ultimate porphyrinogenic metabolite has not been elucidated yet. 6. Disturbances in thyroid hormone (and retinoid) homeostasis can be (at least partially) explained by the formation of halogenated phenol metabolites. 7. In conclusion, for a relevant prediction of the ultimate fate of a compound in a living organism, one should know the chemical characteristics and reactivity of the parent compound and its metabolites, together with insight into the formation mechanism of each of the suspected metabolites, and an understanding of the interaction between a specific chemical (reactive) structure and its target molecule.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D011164 Porphyrias A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues. Porphyria,Porphyrin Disorder,Disorder, Porphyrin,Disorders, Porphyrin,Porphyrin Disorders
D001969 Bromobenzenes Derivatives of benzene in which one or more hydrogen atoms on the benzene ring are replaced by bromine atoms.
D002722 Chlorobenzenes Aromatic organic compounds with the chemical formula C6H5Cln.
D004852 Epoxy Compounds Organic compounds that include a cyclic ether with three ring atoms in their structure. They are commonly used as precursors for POLYMERS such as EPOXY RESINS. Epoxide,Epoxides,Epoxy Compound,Oxiranes,Compound, Epoxy,Compounds, Epoxy
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001555 Benzene Derivatives Organic compounds derived from BENZENE. Derivatives, Benzene

Related Publications

C den Besten, and A Brouwer, and I M Rietjens, and P J van Bladeren
June 1996, Environmental science and pollution research international,
C den Besten, and A Brouwer, and I M Rietjens, and P J van Bladeren
September 1978, Annals of the New York Academy of Sciences,
C den Besten, and A Brouwer, and I M Rietjens, and P J van Bladeren
December 2008, Bulletin of environmental contamination and toxicology,
C den Besten, and A Brouwer, and I M Rietjens, and P J van Bladeren
December 2006, Biomedical and environmental sciences : BES,
C den Besten, and A Brouwer, and I M Rietjens, and P J van Bladeren
January 1985, Drug and chemical toxicology,
C den Besten, and A Brouwer, and I M Rietjens, and P J van Bladeren
July 2005, Bulletin of environmental contamination and toxicology,
C den Besten, and A Brouwer, and I M Rietjens, and P J van Bladeren
January 1991, Critical reviews in biotechnology,
C den Besten, and A Brouwer, and I M Rietjens, and P J van Bladeren
January 1985, Scandinavian journal of work, environment & health,
C den Besten, and A Brouwer, and I M Rietjens, and P J van Bladeren
August 1981, Toxicology and applied pharmacology,
C den Besten, and A Brouwer, and I M Rietjens, and P J van Bladeren
October 1997, Toxicology in vitro : an international journal published in association with BIBRA,
Copied contents to your clipboard!